The Danish Embassy in Washington, DC is pleased to announce an exciting series of virtual seminars led by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) - addressing regulatory developments and trends in the USA and Europe. In the 4-part series of focused sessions, FDA and EMA officials will present how they work together and where they are different in addressing innovation, advancements and approval of new medical products.
Each session will focus on a specific theme addressing related topics and incorporate recent examples and relevant cases.
Sessions will be interactive with a Q&A period following each presentation. Session titles are shown below with detailed descriptions available via the link further below.
March 22: Transatlantic Cooperation in Medical Products Regulation
April 19: What’s new in Oncology
May 17: Patients in Drug Development & Regulatory Processes
June 4: Innovations in Therapy & Digital Transformations
Why attend?
- Hear the latest developments in regulatory science directly from FDA & EMA
- Follow current trends in adapting regulations in the development and innovation of drugs and medical technologies
- Understand critical changes underway to create successful strategies in the USA & Europe
- Benchmark your regulatory strategies against agency requirements
- Reserve a brief private one on one meeting with FDA & EMA officials
Who should attend?
Professionals in Research & Development, Regulatory Affairs, Medical Affairs, Corporate Strategy & Business Development, Market Access & Policy, Health Technology and Patient Advocacy
Interested? How to register
Registration deadline is March 18, 2021.
The registration fee of DKK 1500 per person includes participation in all sessions, materials, a certificate of participation, session recordings, and the opportunity for a brief 1:1 consultation with FDA/EMA officials. Registration for single sessions is not allowed.
In this document, you will find additional details on session descriptions, registration materials, and the option to reserve a 1:1 meeting with FDA & EMA officials. You will also find the registration form to be filled out by you.
Return completed registration form via email to Hans Magnussen [email protected] by March 18, 2021.